Interaction type:
Interactions
Interaction rating:
Potential/Theoritical
Orlistat is a lipase-inhibiting drug used in obesity management. Since this drug functions by inhibiting the absorption of dietary fats, there is the theoretical likelihood that orlistat will inhibit the intestinal absorption of dietary omega-3. Supplementation with the affected nutrient may be necessary. (1) (2)
References
- View Abstract: Heck AM, Yanovski JA, Calis KA. Orlistat, A New Lipase Inhibitor for the Management of Obesity. Pharmacotherapy. Mar2000;20(3):270-9.
- Xenical (orlistat), Product Prescribing Information. Roche Laboratories, Inc. Nutley, New Jersey. Sep2000.
